JACC: Heart Failure Editor's Update, June 2018
Many of our readers already know Dr. JoAnn Lindenfeld. We are lucky to hear her thoughtful, gracious guidance and in-depth analysis of every paper. She is an indispensable part of the team. Her tough, analytical review of papers has earned her the 2017 JACC: HF “Hammer” Award.
Dr. Lindenfeld is Professor of Medicine and Director of the Heart Failure and Transplant Program at Vanderbilt. She began her career investigating the role of anemia in the regulation of cardiac output and this led her to develop the Heart Failure and Transplant Program at the University of Colorado. JoAnn was recently President of the Heart Failure Society of America and has held several leadership roles with the HFSA, including Guideline Committee Chair. She holds leadership roles for large international clinical trials in heart failure and serves on several FDA advisory panels. Her research interests include anticoagulation in LVAD recipients; CRT in patients with Class IV heart failure; and models to determine specific phenotypes for HFpEF. She is a prolific author and her work has informed national policy on heart transplantation and mechanical circulatory support.
3 Things People May Not Know about Me:
- I am addicted to The Voice.
- I am a scratch golfer.
- My brother played football for the University of Michigan.
I look forward to introducing you to other members of our outstanding editorial team in future editions.
NEW FEATURE: POINT/COUNTERPOINT
With the June issue of JACC: Heart Failure, I am introducing a new feature to present two points of view on areas where opinions differ, and I am interested to hear your reaction. The feature is entitled Point/Counterpoint and the topic for this issue is data sharing. I’m anxious to hear your thoughts on open data and your ideas for future topics for discussion in this new section.
- Opening Opportunities With Open Data
Alexander R. Zheutlin, James Brian Byrd
Traveling the Interstices of Data Sharing
Paul W. Armstrong, Robert J. Mentz, Cynthia M. Westerhout
The June issue has a mini-focus issue on "Risk Factors and Outcomes in Chronic Heart Failure" and includes a State-of-the-Art Review by Milton Packer on Worsening Heart Failure During the Use of DPP-4 Inhibitors and several thought-provoking papers on efforts to improve outcomes in chronic heart failure.
- Worsening Heart Failure During the Use of DPP-4 Inhibitors: Pathophysiological Mechanisms, Clinical Risks, and Potential Influence of Concomitant Antidiabetic Medications
- Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry
Marco Canepa, Candida Fonseca, et al
- Health Status Disparities by Sex, Race/Ethnicity, and Socioeconomic Status in Outpatients With Heart Failure
Yevgeniy Khariton, Michael E. Nassif, et al
Prevalence and Prognosetic Significance of Malnutrition Using 3 Scoring Systems Among Outpatients With Heart Failure: A Comparison With Body Mass Index
Shirley Sze, Pierpaolo Pellicori, et al
- Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure
Kevin Damman, Mauro Gori, et al